Oncologic treatment strategies and relative survival of patients with stage I-III rectal cancer - A EURECCA international comparison between the Netherlands, Belgium, Denmark, Sweden, England, Ireland, Spain, and Lithuania

Autor: Esther Bastiaannet, C.J.H. van de Velde, Harm J. T. Rutten, Lene Hjerrild Iversen, Olaf M. Dekkers, H. Ortiz, Anna Martling, G.J. Liefers, A.J. Breugom, Tim J. Evans, Katie M O'Brien, Robert Johansson, Valery E.P.P. Lemmens, R. Janciauskiene, E. Van Eycken, Petra G. Boelens, Sarah Lawton
Přispěvatelé: Public Health, Surgery, RS: GROW - R3 - Innovative Cancer Diagnostics & Therapy
Rok vydání: 2018
Předmět:
Male
Adjuvant chemotherapy
Colorectal cancer
Ireland/epidemiology
Population-based
Rectal Neoplasms/diagnosis
Stage I-III
0302 clinical medicine
ADJUVANT CHEMOTHERAPY
Belgium
Medicine
030212 general & internal medicine
OXALIPLATIN
Stage (cooking)
Rectal cancer
International comparison
POSTOPERATIVE CHEMOTHERAPY
Netherlands
Survival Rate/trends
Postoperative chemotherapy
Relative survival
General Medicine
OPEN-LABEL
Prognosis
Combined Modality Therapy
Survival Rate
Oncology
030220 oncology & carcinogenesis
Population Surveillance
Spain/epidemiology
Treatment strategy
TRIAL
Female
medicine.medical_specialty
Preoperative radiotherapy
education
Netherlands/epidemiology
Disease-Free Survival
CHEMORADIOTHERAPY
03 medical and health sciences
SDG 3 - Good Health and Well-being
Humans
Belgium/epidemiology
PREOPERATIVE RADIOTHERAPY
Aged
Neoplasm Staging
Lithuania/epidemiology
Sweden
business.industry
Rectal Neoplasms
General surgery
TOTAL MESORECTAL EXCISION
Lithuania
medicine.disease
FLUOROURACIL
Spain
Neoplasm staging
Surgery
Oncologic treatment
business
FOLLOW-UP
Ireland
Zdroj: European Journal of Surgical Oncology, 44(9), 1338-1343. W.B. Saunders
EJSO-European Journal of Surgical Oncology, 44(9), 1338-1343
Breugom, A J, Bastiaannet, E, Boelens, P G, Van Eycken, E, Iversen, L H, Martling, A, Johansson, R, Evans, T, Lawton, S, O'Brien, K M, Ortiz, H, Janciauskiene, R, Dekkers, O M, Rutten, H J T, Liefers, G J, Lemmens, V E P P & van de Velde, C J H 2018, ' Oncologic treatment strategies and relative survival of patients with stage I-III rectal cancer-A EURECCA international comparison between the Netherlands, Belgium, Denmark, Sweden, England, Ireland, Spain, and Lithuania ', European Journal of Surgical Oncology, vol. 44, no. 9, pp. 1338-1343 . https://doi.org/10.1016/j.ejso.2018.05.025
European Journal of Surgical Oncology, 44(9), 1338-1343. ELSEVIER SCI LTD
ISSN: 1532-2157
0748-7983
Popis: Introduction: The aim of this EURECCA international comparison is to compare oncologic treatment strategies and relative survival of patients with stage I-III rectal cancer between European countries.Material and methods: Population-based national cohort data from the Netherlands (NL), Belgium (BE), Denmark (DK), Sweden (SE), England (ENG), Ireland (IE), Spain (ES), and single-centre data from Lithuania (LT) were obtained. All operated patients with (y)pTNM stage I-III rectal cancer diagnosed between 2004 and 2009 were included. Oncologic treatment strategies and relative survival were calculated and compared between neighbouring countries.Results: We included 57,120 patients. Treatment strategies differed between NL and BE (p Conclusion: Large differences in oncologic treatment strategies for patients with (y)pTNM I-III rectal cancer were observed across European countries. No clear relation between oncologic treatment strategies and relative survival was observed. Further research into selection criteria for specific treatments could eventually lead to individualised and optimal treatment for patients with non-metastasised rectal cancer. (C) 2018 Published by Elsevier Ltd.
Databáze: OpenAIRE
Externí odkaz: